Notch is out — your watchlist beside the MacBook notch, synced with this account.
Learn more ↗We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
IMBDX is a biotechnology company that develops liquid biopsy-based cancer diagnosis and monitoring technology. Its main business areas include early cancer detection, recurrence monitoring, and companion diagnostics. The company offers products such as CancerScan and CancerMonitor, which utilize circulating tumor DNA (ctDNA) analysis. IMBDX operates within the precision medicine and medical diagnostics industries.
아이엠비디엑스는 액체 생검 기반의 암 진단 및 모니터링 기술을 개발하는 생명공학 기업입니다. 주요 사업 영역은 암 조기 진단, 재발 모니터링, 동반 진단이며, 순환 종양 DNA(ctDNA) 분석을 활용한 CancerScan, CancerMonitor 등의 제품을 제공합니다. 정밀 의료 및 의료 진단 산업에 속해 있습니다.
